Single-cell transcriptomic profiles reveal changes associated with BCG-induced trained immunity and protective effects in circulating monocytes.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
16 11 2021
Historique:
received: 21 12 2020
revised: 31 08 2021
accepted: 29 10 2021
entrez: 17 11 2021
pubmed: 18 11 2021
medline: 15 2 2022
Statut: ppublish

Résumé

Bacillus Calmette-Guérin (BCG) vaccine is one of the most widely used vaccines worldwide. In addition to protection against tuberculosis, BCG confers a degree of non-specific protection against other infections by enhancing secondary immune responses to heterologous pathogens, termed "trained immunity." To better understand BCG-induced immune reprogramming, we perform single-cell transcriptomic measurements before and after BCG vaccination using secondary immune stimulation with bacterial lipopolysaccharide (LPS). We find that BCG reduces systemic inflammation and identify 75 genes with altered LPS responses, including inflammatory mediators such as CCL3 and CCL4 that have a heightened response. Co-expression analysis reveals that gene modules containing these cytokines lose coordination after BCG. Other modules exhibit increased coordination, including several humanin nuclear isoforms that we confirm induce trained immunity in vitro. Our results link in vivo BCG administration to single-cell transcriptomic changes, validated in human genetics experiments, and highlight genes that are putatively responsible for non-specific protective effects of BCG.

Identifiants

pubmed: 34788625
pii: S2211-1247(21)01510-2
doi: 10.1016/j.celrep.2021.110028
pmc: PMC8728743
mid: NIHMS1757902
pii:
doi:

Substances chimiques

BCG Vaccine 0
Cytokines 0
Inflammation Mediators 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110028

Subventions

Organisme : European Research Council
ID : 833247
Pays : International
Organisme : NIDDK NIH HHS
ID : RC2 DK114784
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests R.J.X. is co-founder of Celsius Therapeutics and Jnana Therapeutics. M.G.N. and L.A.B.J. are scientific founders of Trained Therapeutix and Discovery (TTxD).

Références

Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
Trends Immunol. 2013 Sep;34(9):431-9
pubmed: 23680130
Autophagy. 2016;12(2):245-60
pubmed: 26222012
Bioinformatics. 2012 Jun 15;28(12):1598-603
pubmed: 22500001
J Clin Invest. 2020 Oct 1;130(10):5591-5602
pubmed: 32692728
BMC Res Notes. 2014 Dec 11;7:901
pubmed: 25495213
Allergy. 2020 Jul;75(7):1815-1819
pubmed: 32339299
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17537-42
pubmed: 22988082
Vaccine. 2010 Jul 26;28(33):5427-31
pubmed: 20558246
Pharmacol Rep. 2010 Sep-Oct;62(5):767-77
pubmed: 21098860
J Cell Biol. 1990 Feb;110(2):283-94
pubmed: 2298808
Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
Metabolism. 2010 Mar;59(3):343-9
pubmed: 19800083
Mol Genet Genomic Med. 2020 Oct;8(10):e1442
pubmed: 32744436
Proc Soc Exp Biol Med. 1976 May;152(1):57-60
pubmed: 177992
Cell Host Microbe. 2020 Aug 12;28(2):322-334.e5
pubmed: 32544459
Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5
pubmed: 29324233
J Biol Chem. 2013 Feb 22;288(8):5381-8
pubmed: 23322776
Infect Immun. 1983 Mar;39(3):1029-40
pubmed: 6341226
Front Oncol. 2015 Apr 28;5:100
pubmed: 25973397
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Nat Commun. 2019 Feb 20;10(1):874
pubmed: 30787276
BMC Public Health. 2015 Feb 22;15:175
pubmed: 25886062
Nat Rev Immunol. 2020 Jun;20(6):375-388
pubmed: 32132681
Neurochem Res. 2013 Mar;38(3):581-8
pubmed: 23277413
J Alzheimers Dis. 2015;46(1):145-50
pubmed: 25720405
N Engl J Med. 2018 Jul 12;379(2):138-149
pubmed: 29996082
Cell Host Microbe. 2020 Jun 10;27(6):883-890.e2
pubmed: 32407669
PLoS Pathog. 2014 Oct 30;10(10):e1004485
pubmed: 25356988
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Nat Rev Immunol. 2020 Jun;20(6):335-337
pubmed: 32393823
Cell. 2020 Oct 15;183(2):315-323.e9
pubmed: 32941801
PLoS Med. 2011 Mar;8(3):e1001012
pubmed: 21445325

Auteurs

Lingjia Kong (L)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Computational and Integrative Biology and Department of Molecular Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Simone J C F M Moorlag (SJCFM)

Department of Internal Medicine, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.

Ariel Lefkovith (A)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Bihua Li (B)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Computational and Integrative Biology and Department of Molecular Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Vasiliki Matzaraki (V)

Department of Internal Medicine, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.

Liesbeth van Emst (L)

Department of Internal Medicine, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.

Heather A Kang (HA)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Isabel Latorre (I)

Center for Computational and Integrative Biology and Department of Molecular Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Martin Jaeger (M)

Department of Internal Medicine, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.

Leo A B Joosten (LAB)

Department of Internal Medicine, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Department of Medical Genetics, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca 400000, Romania.

Mihai G Netea (MG)

Department of Internal Medicine, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Department for Immunology and Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, 53115 Bonn, Germany. Electronic address: mihai.netea@radboudumc.nl.

Ramnik J Xavier (RJ)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Computational and Integrative Biology and Department of Molecular Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: xavier@molbio.mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH